Abstract
Since early Greek times, animals have provided knowledge critical to understanding human anatomy, physiology, disease injuries, development of medicines, vaccines, diagnostics and much more. The questions asked and the experiments designed have changed over time; most dramatically with increased genetic and immunologic insights of the past 20 years. In research within the pharmaceutical industry animals have been important in the discovery of new medicines and treatments. In animal models, new modalities are studies for their ability to turn on or off a receptor, to understand target and off target effects, induce mechanisms of actions and other investigative questions, tied to clinical questions and trial design. Recently the translatability between preclinical (animal) and clinical (human) studies have been questioned. This paper will review why animal models are important in drug discovery using select pharmacologic models, a brief review of the importance of animals and the brutality and outcomes of vivisection, and the problems of translation and bioethical questions about the use of animals in drug research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Adams, B., & Larson, J. (2016). Legislative history of the animal welfare act: Introduction.
Alter, H. J., Houghton, M., & Rice, C. M. (2020). Hepatitis C virus: Discovery to future prospects. Current Science, 119(10), 1606.
Avila, A. M., Bebenek, I., Bonzo, J. A., Bourcier, T., Bruno, K. L. D., Carlson, D. B., et al. (2020). An FDA/CDER perspective on nonclinical testing strategies: Classical toxicology approaches and new approach methodologies (NAMs). Regulatory Toxicology and Pharmacology, 114, 104662.
Baptista, C. V. J., Faustino-Rocha, A. I., & Oliveira, P. A. (2021). Animal models in pharmacology: A brief history awarding the nobel prizes for physiology or medicine. Pharmacology, 106(7–8), 356–368.
Barefield, D. Y. (2017). It takes a village to train a scientist. American Heart Association.
Bates, D. G. (1992). Harvey’s account of his “discovery”. Medical History, 36(4), 361–378.
Bates, A. (2014). Vivisection, virtue ethics, and the law in 19th-century Britain. Journal of Animal Ethics, 4(2), 30–44.
Bates, A. (2017). Anti-vivisection and the profession of medicine in Britain: A social history. Springer Nature.
Beauchamp, T. & DeGrazia, D. (2020). Principles of Animal Research. Oxford University Press.
Beekman, F. (1936). Studies in aneurysm by William and John Hunter. Annals of Medical History, 8(2), 124.
Bruers, S. (2015). The core argument for veganism. Philosophia, 43(2), 271–290.
Chateau-Joubert, S., Hopfe, M., Richon, S., Decaudin, D., Roman-Roman, S., Reyes-Gomez, E., et al. (2021). Spontaneous mouse lymphoma in patient-derived tumor xenografts: The importance of systematic analysis of xenografted human tumor tissues in preclinical efficacy trials. Translational Oncology, 14(8), 101133.
Chaudhary, K., Chattopadhyay, A., & Pratap, D. (2018). The evolution of CRISPR/Cas9 and their cousins: Hope or hype? Biotechnology Letters, 40(3), 465–477.
Clark, J. M. (2018). The 3Rs in research: A contemporary approach to replacement, reduction and refinement. British Journal of Nutrition, 120(s1), S1–S7.
Crabbe, J. C. (2016). Reproducibility of experiments with laboratory animals: What should we do now? Alcoholism: Clinical and Experimental Research, 40(11), 2305–2308.
Denayer, T., Stöhr, T., & Van Roy, M. (2014). Animal models in translational medicine: Validation and prediction. New Horizons in Translational Medicine, 2(1), 5–11.
Dunn, D. A., Pinkert, C. A., & Kooyman, D. L. (2005). Foundation review: Transgenic animals and their impact on the drug discovery industry. Drug Discovery Today, 10(11), 757–767.
Ericsson, A. C., Crim, M. J., & Franklin, C. L. (2013). A brief history of animal modeling. Missouri Medicine, 110(3), 201.
Everitt, J., & Berridge, B. (2017). The role of the IACUC in the design and conduct of animal experiments that contribute to translational success. ILAR Journal, 58(1), 129–134.
Feinberg, J. (2017). Human duties and animal rights (pp. 399–423). Routledge.
Ferreira, G. S., Veening-Griffioen, D. H., Boon, W. P., Moors, E. H., & van Meer, P. J. (2020). Levelling the translational gap for animal to human efficacy data. Animals, 10(7), 1199.
Festing, M. F. (2020). The “completely randomised” and the “randomised block” are the only experimental designs suitable for widespread use in pre-clinical research. Scientific Reports, 10(1), 1–5.
Finn, M. A., & Stark, J. F. (2015). Medical science and the cruelty to animals act 1876: A re-examination of anti-vivisectionism in provincial Britain. Studies in History and Philosophy of Science Part C: Studies in History and Philosophy of Biological and Biomedical Sciences, 49, 12–23.
Finsen, L., & Finsen, S. (1994). The animal rights movement in America: From compassion to respect. Social movements past and present (USA). Twayne Publishers.
Franco, N. H. (2013). Animal experiments in biomedical research: A historical perspective. Animals, 3(1), 238–273.
Frommlet, F. (2020). Improving reproducibility in animal research. Nature Publishing Group.
Gettayacamin, M., & Retnam, L. (2017). AAALAC international standards and accreditation process. Toxicological Research, 33(3), 183–189.
Glatigny, S., & Bettelli, E. (2018). Experimental autoimmune encephalomyelitis (EAE) as animal models of multiple sclerosis (MS). Cold Spring Harbor Perspectives in Medicine, 8(11), a028977.
Gregory, N. S., Harris, A. L., Robinson, C. R., Dougherty, P. M., Fuchs, P. N., & Sluka, K. A. (2013). An overview of animal models of pain: Disease models and outcome measures. The Journal of Pain, 14(11), 1255–1269.
Griffin, G., & Locke, P. (2016). Comparison of the Canadian and US laws, regulations, policies, and systems of oversight for animals in research. ILAR Journal, 57(3), 271–284.
Grimm, H., Olsson, I. A. S., & Sandøe, P. (2019). Harm–benefit analysis–what is the added value? A review of alternative strategies for weighing harms and benefits as part of the assessment of animal research. Laboratory Animals, 53(1), 17–27.
Guillén, J. (2017). Laboratory animals: Regulations and recommendations for the care and use of animals in research. Academic Press.
Guillén, J., Gettayacamin, M., & Swearengen, J. R. (2017). Challenges and opportunities in implementation: The AAALAC international perspective. ILAR Journal, 57(3), 368–377.
Hajar, R. (2011). Animal testing and medicine. Heart views: the official journal of the Gulf Heart Association, 12(1), 42.
Hollands, C. (1986). The animals (scientific procedures) act 1986. Lancet (London, England), 2(8497), 32–33.
Hubrecht, R. C., & Carter, E. (2019). The 3Rs and humane experimental technique: Implementing change. Animals, 9(10), 754.
Kahn, J. (2012). Raising the bar: The implications of the IOM report on the use of chimpanzees in research. Hastings Center Report, 42(s1), S27–S30.
Kaklamanis, P. M. (1992). Experimental animal models resembling rheumatoid arthritis. Clinical Rheumatology, 11(1), 41–47.
Kang, H. (2021). Statistical messages from ARRIVE 2.0 guidelines. The Korean Journal of Pain, 34(1), 1.
Karp, N. A., Wilson, Z., Stalker, E., Mooney, L., Lazic, S. E., Zhang, B., & Hardaker, E. (2020). A multi-batch design to deliver robust estimates of efficacy and reduce animal use–a syngeneic tumour case study. Scientific Reports, 10(1), 1–10.
Kilkenny, C., Browne, W., Cuthill, I. C., Emerson, M., & Altman, D. G. (2010). Animal research: Reporting in vivo experiments: The ARRIVE guidelines. British Journal of Pharmacology, 160(7), 1577–1579.
King, A., & Bowe, J. (2016). Animal models for diabetes: Understanding the pathogenesis and finding new treatments. Biochemical Pharmacology, 99, 1–10.
Kinter, L. B., DeHaven, R., Johnson, D. K., & DeGeorge, J. J. (2021). A brief history of use of animals in biomedical research and perspective on non-animal alternatives. ILAR journal, 62, 7–16.
Kooijman, M. (2013). Why animal studies are still being used in drug development. Alternatives to Laboratory Animals, 41(6), P79–P81.
Macleod, M., & Mohan, S. (2019). Reproducibility and rigor in animal-based research. ILAR Journal, 60(1), 17–23.
Mak, I. W., Evaniew, N., & Ghert, M. (2014). Lost in translation: Animal models and clinical trials in cancer treatment. American Journal of Translational Research, 6(2), 114.
McGonigle, P., & Ruggeri, B. (2014). Animal models of human disease: Challenges in enabling translation. Biochemical Pharmacology, 87(1), 162–171.
Meehan, T. F. (2019). Know thy PDX model. Cancer Research, 79(17), 4324–4325.
Miyoshi, M., & Liu, S. (2018). Collagen-induced arthritis models rheumatoid arthritis (pp. 3–7). Springer.
Muñoz-Fontela, C., Dowling, W. E., Funnell, S. G., Gsell, P.-S., Riveros-Balta, A. X., Albrecht, R. A., et al. (2020). Animal models for COVID-19. Nature, 586(7830), 509–515.
National Research Council. (2011). Chimpanzees in biomedical and behavioral research: Assessing the necessity. National Academies Press.
Noble, D. (2008). Claude Bernard, the first systems biologist, and the future of physiology. Experimental Physiology, 93(1), 16–26.
Ogle, W. (2014). Parts of animals complete works of Aristotle (Vol. 1, pp. 994–1086). Princeton University Press.
Olson, M. V., & Varki, A. (2003). Sequencing the chimpanzee genome: Insights into human evolution and disease. Nature Reviews Genetics, 4(1), 20–28.
Olsson, I. A. S., Silva, S. P. d., Townend, D., & Sandøe, P. (2017). Protecting animals and enabling research in the European Union: An overview of development and implementation of directive 2010/63/EU. ILAR Journal, 57(3), 347–357.
Pandey, K., Acharya, A., Mohan, M., Ng, C. L., Reid, S. P., & Byrareddy, S. N. (2021). Animal models for SARS-CoV-2 research: A comprehensive literature review. Transboundary and Emerging Diseases, 68(4), 1868–1885.
Percie du Sert, N., Hurst, V., Ahluwalia, A., Alam, S., Avey, M. T., Baker, M., et al. (2020). The ARRIVE guidelines 2.0: Updated guidelines for reporting animal research. Journal of Cerebral Blood Flow & Metabolism, 40(9), 1769–1777.
Ransohoff, R. M. (2012). Animal models of multiple sclerosis: The good, the bad and the bottom line. Nature Neuroscience, 15(8), 1074–1077.
Régnier, C. (2013). Claude Bernard (1813–1878) and experimental medicine “physiology, physiology, it’s in me…”. Medicographia, 35, 474–484.
Rivera, E. A. B., Hernández-González, R., Carbone, C., Baamonde, J. M., Rivera, T. A. B., & Carissimi, A. S. (2018). Laboratory animal legislation in Latin America. In Laboratory animals (pp. 91–116). Elsevier.
Roep, B. O., Buckner, J., Sawcer, S., Toes, R., & Zipp, F. (2012). The problems and promises of research into human immunology and autoimmune disease. Nature Medicine, 18(1), 48–53.
Schultz, S. G. (2002). William Harvey and the circulation of the blood: The birth of a scientific revolution and modern physiology. Physiology, 17(5), 175–180.
Schwindaman, D. F. (1999). The history of the animal welfare act. In C. W. McPherson & S. F. Mattingly (Eds.), 50 years of laboratory animal science (pp. 147–151). American Association for Laboratory Animal Science.
Shackelford, J. (2003). William Harvey and the mechanics of the heart. Oxford University Press.
Shaffer, C. (2021). Long-awaited NIH working group report on animal research rigor: ‘a good start’. Nature Portfolio.
Silverman, J., Suckow, M. A., & Murthy, S. (2014). The IACUC handbook. CRC Press.
Snoy, P. (2010). Establishing efficacy of human products using animals: The US food and drug administration’s “animal rule”. Veterinary Pathology, 47(5), 774–778.
Studholme, L., Sutherland, J., Desai, T., Hockley, J., Care, R., Nordgren, I. K., et al. (2019). Evaluation of the monocyte activation test for the safety testing of meningococcal B vaccine Bexsero: A collaborative study. Vaccine, 37(29), 3761–3769.
Tadenev, A. L., & Burgess, R. W. (2019). Model validity for preclinical studies in precision medicine: Precisely how precise do we need to be? Mammalian Genome, 30(5), 111–122.
Törnell, J., & Snaith, M. (2002). Transgenic systems in drug discovery: From target identification to humanized mice. Drug Discovery Today, 7(8), 461–470.
Valentini, S., Santoro, G., Baffetta, F., Franceschi, S., Paludi, M., Brandini, E., et al. (2019). Monocyte-activation test to reliably measure the pyrogenic content of a vaccine: An in vitro pyrogen test to overcome in vivo limitations. Vaccine, 37(29), 3754–3760.
Vasbinder, M. A., & Locke, P. (2016). Introduction: Global laws, regulations, and standards for animals in research. ILAR Journal, 57(3), 261–265.
Veenhuis, R. T., & Zeiss, C. J. (2021). Animal models of COVID-19 II. Comparative immunology. ILAR Journal, 62, 17–34.
Veening-Griffioen, D. H., Ferreira, G. S., van Meer, P. J., Boon, W. P., Gispen-de Wied, C. C., Moors, E. H., & Schellekens, H. (2019). Are some animal models more equal than others? A case study on the translational value of animal models of efficacy for Alzheimer’s disease. European Journal of Pharmacology, 859, 172524.
Veening-Griffioen, D. H., Ferreira, G. S., Boon, W. P., Gispen-de Wied, C. C., Schellekens, H., Moors, E. H., & Van Meer, P. J. (2021). Tradition, not science, is the basis of animal model selection in translational and applied research. ALTEX-Alternatives to Animal Experimentation, 38(1), 49–62.
Yasinski, E. (2018). Study questions animal efficacy data behind trials. American Association for the Advancement of Science.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Landi, M.S. (2023). Animals in Research in the Pharmaceutical Industry. In: Valdés, E., Lecaros, J.A. (eds) Handbook of Bioethical Decisions. Volume I. Collaborative Bioethics, vol 2. Springer, Cham. https://doi.org/10.1007/978-3-031-29451-8_29
Download citation
DOI: https://doi.org/10.1007/978-3-031-29451-8_29
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-29450-1
Online ISBN: 978-3-031-29451-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)